期刊文献+

纳米粒子介导血管内皮生长因子基因转染的实验研究

Nanoparticle as a new gene transferring vector in VEGF gene transfection
暂未订购
导出
摘要 目的 观察纳米粒子携带血管内皮生长因子(VEGFl65)基因转染的可行性。方法 应用聚乳酸聚乙醇酸共聚物(PL-GA)和聚乙烯醇(PVA)包载VEGFl65基因质粒,制备纳米级粒子混合物,检测其载药量、体外释放情况及粒径;培养心肌细胞,应用RT-PCR及ELISA方法观察纳米级粒子混合物为真核细胞传递基因的可行性;将纳米粒子悬浮液注射至活体家兔心肌组织内,96h后电镜观察其向心肌组织内传递基因的可行性。结果 制备的纳米粒子载药量为1.87%,粒径为25~300nm;RT-PCR和ELISA结果提示纳米粒子可将目的基因转移至心肌细胞中;体内实验显示心肌细胞胞质内及胞核内可见大量被吞噬的纳米粒子。结论 纳米粒子可作为向心肌组织转运VEGF基因的载体。 Objective To evaluate the possibility and efficiency of nanoparticles as a new vector in vascular endothelial growth factor (VEGF) gene transfection. Methods Nanoparticle-VEGF (Np/VEGF)complex was prepared with poly (D, L-lactide co-glycolide) (PLGA) loading VEGF165 gene using the multiple emulsion (w/o/w) technique. The envelopment efficiency and size of the complex were determined. Rat myocardial cells were cultured in vitro, and the Np/VEGF was transfected into the cultured myocardial cells. Then RT-PCR and ELISA were used to evaluate whether the Np/VEGF increased the level of gene expression. Four New Zealand rabbits were used, the suspension of Np/VEGF was injected into myocardial tissue of rabbits after thoracotomy. 96h after the operation, the tissue sections of the implant sites were observed with transmission electron microscope (TEM) to determine the process of nanoparticles as vectors for gene transfer to cardiac myocytes. Results The envelopment efficiency and size of the Np/VEGF complex thus prepared were 1.87% and 25-300nm respectively. RT-PCR and ELISA showed that VEGF gene could be successfully transfected into myocardial cells by nanoparticle, and NP/VEGF significantly enhanced gene transfection efficiency, and it was more effective than plasmid. 96h after the operation, a great number of nanoparticles were observed in myocardial cytoplasm and nucleus with TEM, and many nanoparticles began to dissolve and degrade, suggesting that the DNA was released slowly from the nanoparticles localized in the cytoplasmic compartment, and was then transferred into the nucleus. Condusions NP/VEGF can act as a vector to transfect VEGF gene in vitro and in vivo, it significantly enhanced gene transfection efficiency, and it was more effective than plasmid.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2006年第3期213-215,共3页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金(30300456)
关键词 转染 纳米粒子 血管内皮生长因子类 transfection nanoparticle vascular endothelial growth factors
  • 相关文献

参考文献7

  • 1Thurmond KB,Remsen EE,Kowalewski T et al.Packaging of DNA by shell crosslinked nanoparticles.Nucleic Acids Res,1999,27:2966
  • 2Prabha S,Zhou WZ,Panyam J et al.Size-dependency of nanoparticlemediated gene transfection:studies with fractionated nanoparticles,Int J Pharm,2002,244:105
  • 3Schwarz ER,Speakman MT,Patterson M et al.Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation.J Am Coll Cardiol,2000,35:1323
  • 4李拥军,管珩,刘昌伟,郑曰宏,赵三妹,王宗立,杨菁,宋存先.纳米粒子介导特异基因转染的实验研究[J].中华医学杂志,2002,82(5):341-344. 被引量:21
  • 5易甫,吕安林,贾国良,张荣庆.血管内皮细胞生长因子真核表达质粒的构建及其在心肌细胞中的表达[J].心脏杂志,2003,15(3):218-222. 被引量:5
  • 6Losordo DW,Vale PR,Symes JF et al.Gene therapy for myocardial angiogenesis:initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.Circulation,1998,98:2800
  • 7Losordo DW,Vale PR,Hendel RC et al.Phase 1/2 placebo-controlled,double-blind,dose-escalating trial of myocardial vascular endo thelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia.Circulation,2002,105:2012

二级参考文献12

  • 1Folkman J,Shing Y. Angiogenesis[J]. J Biol Chem, 1992,267(16) :10931--10934.
  • 2Neufeld G,Cohen T,Stela G,et al. Vascular endothelial growth factor (VEGF) and its receptors [J]. FASEB J, 1999,13 (1): 9--22.
  • 3Mack CA, Patel SR, Schwarz EA,et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular enthelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart [J]. J Thorac Cardiovasc Surg, 1998,115 ( 1 ): 168--177.
  • 4Tio RA ,Tkehuchava T,Scheuermann TH ,et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardial[J]. Hum Gene Ther,1999,10(18) ,2953--2960.
  • 5Schwarz ER, Speskman MT, Patterson M,et al. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation[J]. J Am Coll Cardiol, 2000,35( 5):1323--1330.
  • 6Losordo DW,Vale PR,Symes JF,et al. Gene therapy for myocardial angiogenesis initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia[J]. Circulation,1998, 98(25):2800--2804.
  • 7Rosengart TK, Lee LY,Patel SR ,et al. Six-- month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA[J]. Ann Surg,1999,230(4):466--472.
  • 8Symes JF,Losordo DW,Vale PR,et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease[J]. Ann Thorac surg, 1999,68 (3): 830-- 837.
  • 9Neufeld G,Cohen T,Gitay-Goren H,et al. Similarities and difference between the vascular endothelial growth factor(VEGF)splice variants cancer[J]. Cancer Metastasis Rev, 1996, 15(2) :153--158.
  • 10Song CX,Labhasetwar V,Murphy H,et al.Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery[].Journal of Controlled Release.1997

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部